Monday, October 3, 2022


Biotechnology News Magazine

John Tourlas Appointed President of Medicom’s North American Business Unit: Effective January 4

Latest Posts

City of Hope to Accelerate Immunotherapy Research & Treatment Innovation with $15 Mil Gift from Ted Schwartz Family

Ted Schwartz, who is now cancer free, achieved complete remission at City of Hope in 2020 with the center's leading CAR T cell therapy after a 16-year battle with lymphoma, provided the gift to City of Hope to advance treatment options that offer better outcomes and quality of life for people living with cancer.

Neurocrine Biosciences Appoints Dr Ingrid Delaet as Chief Regulatory Officer

Prior to joining Neurocrine Biosciences, Dr Ingrid Delaet served as Senior Vice President, Regulatory Affairs at Intercept Pharmaceuticals, which she joined in 2016.

Astrea Bioseparations Introduces Nereus LentiHERO, a Fit-for-purpose Solution for Lentiviral Vector Purification

“We believe that AstreAdept will be a game-changer,” explained Astrea Bioseparations’ CEO Terry Pizzie. “Our approach was to rapidly develop and incorporate this material into the Nereus LentiHERO, a simple, fit-for-purpose device that radically transforms how lentivirus can be purified [in terms of speed, recovery, and efficiency].

At Pack Expo, Schreiner MediPharm to Debut Functional Labels Designed from More Sustainable Materials

Schreiner MediPharm advises he new label concepts are based on existing items in Schreiner MediPharm’s roster of functional labeling solutions.

January 25, 2021

John Tourlas has been appointed President of Medicom’s North American Business Unit.

John Tourlas is a seasoned leader with 30 years of experience and extensive strategic and operational expertise in international business management. Over the course of his career, his in-depth knowledge of the manufacturing and distribution business model has produced multiple financial and operational success stories.

Until recently, Mr. Tourlas served as Global Vice President and General Manager of the Laboratory Products Division of Thermo Fisher Scientific, a long-time Medicom customer. In this capacity, he oversaw six global manufacturing sites, managed a leadership team of eleven and gained a solid understanding of the competitive landscape, suppliers and customers. Originally from Montreal, this is a return to his roots for Mr. Tourlas.

Mr. Tourlas will lead Medicom’s entire North American business unit and assist in the development of ongoing strategies and tactics across all activities, channels and products. He will help the organization achieve its short and long-term goals, influence the direction of the business and contribute to the development of world-class operational and commercial structures.

Commenting on the appointment, Ronald Reuben, Medicom Chief Executive Officer, said, “John’s knowledge of our industry, our management team and our overall strategic direction will enable him to quickly integrate into his new role. This is an important advantage, as Medicom is growing faster than ever to meet the exponential demand for personal protective equipment and other infection control products due to the COVID-19 pandemic.”

Following Mr. Tourlas’ appointment and integration, Guillaume Laverdure will refocus on his role as Chief Operating Officer of the Medicom Group, leading the expansion of production facilities worldwide, and Ouriel Levy will focus on his role as Global President of the Dental Division and assume greater responsibility at the Group level.


Latest Posts

Learn More




Our Sister Publication

Medical Device News Magazine